Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Lastest Finance News

High Court challenge over decision to expand Luton Airport dismissed

8th Dec 2025 12:19

(Alliance News) - A High Court challenge against the government's approval of plans to expand Luton Airport has been dismissed by a judge. Read More

CRH set to join S&P 500 later in December after index review

8th Dec 2025 12:19

(Alliance News) - CRH PLC is to join the S&P 500 later this month, according to an index rebalancing announced on Friday. Read More

LONDON MARKET MIDDAY: Stocks mixed as Wednesday US rate call nears

8th Dec 2025 12:07

(Alliance News) - Stock prices in London were mostly lower at midday on Monday, ahead of US consumer inflation expectations and comments from the Bank of England's deputy governor. Read More

DIRECTOR DEALINGS: GBP5 million sale of Value & Indexed Property stock

8th Dec 2025 12:06

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and Monday and not separately reported by Alliance News: Read More

Greengage & Co plans float on Aquis Stock Exchange to expand platform

8th Dec 2025 11:53

(Alliance News) - Greengage & Co Group PLC on Monday said it intends to float on the Access segment of the Aquis Stock Exchange, alongside an accompanying fundraise. Read More

TRADING UPDATES: Hercules wins pacts; Mears in strong second half

8th Dec 2025 11:44

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: Avacta to announce initial phase 1b data on faridoxorubicin

8th Dec 2025 11:41

Avacta Group PLC - Wetherby, West Yorkshire-based life sciences company - Expects to announce initial faridoxorubicin phase 1b data in the salivary gland cancer indication next week Wednesday. Back in October, Avacta had said faridoxorubicin showed positive tolerability and safety in patents across both the every three weeks and every two weeks dosing regiments. Faridoxorubicin is a form of doxorubicin designed to reduce the systemic side effects of conventional chemotherapy and concentrate the active payload in the tumour microenvironment. Doxorubicin is a chemotherapy drug used to treat cancer. Read More

EXECUTIVE CHANGES: Oxford Nanopore Tech hires new CEO from Danaher

8th Dec 2025 11:24

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and Monday and not separately reported by Alliance News: Read More

Hutchmed drugs stay on NRDL; Tazverik added to new insurance list

8th Dec 2025 11:15

(Alliance News) - Hutchmed China Ltd on Monday said several of its oncology medicines will continue to be reimbursed under China's national insurance scheme next year, while one of its newer cancer drugs has secured a place on the country's first-ever commercial insurance drug list. Read More

Xcel Energy agrees electricity supply to Fermi's power grid project

8th Dec 2025 11:09

(Alliance News) - Fermi Inc on Monday reported a definitive deal for Xcel Energy Inc to supply electric services to its Matador energy grid project. Read More

SMALL-CAP WINNERS: Mears rises as annual profit set to beat forecasts

8th Dec 2025 10:59

(Alliance News) - The following stocks are the leading risers among London Main Market small-caps on Monday. Read More

Anglo scraps plans to award executive bonuses related to Teck merger

8th Dec 2025 10:45

(Alliance News) - Anglo American PLC on Monday said it has withdrawn a proposed amendment to raise minimum vesting of the share awards for 2024 and 2025 following shareholder concerns. Read More

AIM WINNERS & LOSERS: Frontier IP loss widens in tough year

8th Dec 2025 10:44

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More

Power Probe targets GBP60 million valuation as announces IPO pricing

8th Dec 2025 10:22

(Alliance News) - Power Probe PLC on Monday said it is targetting a market valuation of GBP60.4 million when it starts trading on the London Stock Exchange's AIM market on Thursday. Read More

Smith & Nephew guides growth out to 2028 as set to meet target in 2025

8th Dec 2025 10:19

(Alliance News) - Smith & Nephew PLC on Monday announced targets for 2028, aiming for revenue and profit growth, as it is set to meet its goals for 2025. Read More

FTSE 100 Latest
Value9,687.18
Change31.65